Influenza B Triggers Earlier, More Robust Immune Response Than Influenza A, Study Finds
核心洞察
A mouse model study found that influenza B (搜索) virus (IBV) elicits significantly earlier innate and adaptive immune responses compared to influenza A (搜索) virus (IAV).
IFNγ levels in IBV-infected lungs were over 500 times greater at day 6, driven by a 10-fold increase in CD4 and CD8 T cell recruitment.
The accelerated immune response in IBV infection led to earlier viral clearance, suggesting protective immunity develops more rapidly against influenza B (搜索).
A new study published in The Journal of Immunology has revealed that influenza B (搜索) virus (IBV) triggers a significantly earlier and more robust immune response in the lungs compared to influenza A (搜索) virus (IAV), challenging the long-standing research focus that has predominantly centered on IAV. The findings carry important implications for vaccine development, given that IBV accounts for approximately 25% of yearly influenza infections and poses a significant risk for children.
The research, led by Dr. Andrea Sant, Professor of Microbiology and Immunology at the University of Rochester Medical School (搜索), used a mouse model to characterize pulmonary immune responses to IBV B/Brisbane/60/2008 compared to IAV A/California/04/2009 between days 3 and 7 post-infection.
IFNγ Response and T Cell Recruitment
One of the most striking findings was the magnitude of the interferon-gamma (IFNγ) response. IFNγ detected in lung lysates was over 500 times greater in IBV-infected mice at day 6 relative to IAV-infected mice at the same time point. This dramatic difference was driven by a significantly earlier recruitment of IFNγ-producing CD4 and CD8 T cells, which were 10-fold more abundant in IBV-infected lungs compared to IAV or naïve controls.
Furthermore, CD4 and CD8 T cells isolated from IBV-infected lungs produced IFNγ at a significantly higher abundance than those from IAV-infected lungs. The researchers noted that the kinetics of T cell infiltration in response to IBV infection was unexpected, given that the IAV-specific CD4 T cell response has been shown to peak around day 10 post-infection.
Innate Immune Activation and Viral Clearance
The study also documented increased Ly6C-high inflammatory monocytes—which also produce IFNγ—and higher levels of IP-10 and MIP-1β (搜索), pro-inflammatory cytokines that recruit immune cells, in the IBV-infected lung. This heightened innate immune activation was accompanied by earlier clearance of IBV compared to IAV from the infected lung.
"Essentially, protective immunity is generated more rapidly in response to IBV as IBV initiates an innate response to infection more quickly than IAV does, which accelerates the protective T cell response in the lung," said Dr. Sant.
Implications for Vaccine Improvement
Current understanding of innate and adaptive immune responses to influenza virus infection is almost exclusively based on studies of IAV. The researchers emphasize that improved vaccines and therapeutic agents to prevent and treat influenza B (搜索) depend on increased understanding of the innate and adaptive immune cells that localize to the site of infection and contribute to viral clearance.
"We hope that our findings will lead to research that improves understanding of the earliest events in IBV vs IAV infection within the complex cellular microenvironment of the lung, using contemporary influenza viruses," Dr. Sant added.
Beyond expanding this work to other IAV and IBV strains, the research team is now focused on identifying the chemokine mediators responsible for recruitment of IAV- and IBV-specific T cells to the lung and the sites of action of these chemokines in vivo.